Board Organizes Working Group on Access to Drug Labels
The working group will develop best practices for pharmacies on providing independent access to prescription drug container labels. Various alternatives will be explored, including braille, large print labels, and auditory technologies such as "talking bottles" and radio frequency identification tags. The Board gained the responsibility to address this issue under the "Food and Drug Administration Safety and Innovation Act" which was signed into law in July. The law also calls upon the National Council on Disability to conduct an informational and educational campaign in cooperation with the stakeholder working group to inform the public, including people with disabilities and pharmacists, of the best practices.
Public Comments on Bus Access Ramps Due October 31
As previously noted, the Board has re-opened the rulemaking docket in order to collect additional information and feedback from the public on bus ramps. This information will be used to finalize proposed updates to sections of the guidelines covering buses and vans. Comments are due October 31 and can be submitted through regulations.gov. Comments received after this date will be considered to the extent practicable. The Board held public meetings on this subject in Washington, D.C. on September 19 and in Seattle at the annual meeting of the American Public Transportation Association on October 2.
Upcoming Board Webinars
The following webinar, to be held December 6 from 2:30 - 4:00 (ET), will provide an overview and update on new accessibility standards the Board is developing for medical diagnostic equipment.
The webinar series is made available in cooperation with the ADA National Network. For more information, including registration instructions, visit www.accessibilityonline.org. Questions for webinars can be submitted in advance through this website. Archived copies of previous Board webinars are also available on the site.
Access Currents is a free newsletter issued by the Access Board every other month by mail and e-mail. Send questions or comments to email@example.com or call (800) 872-2253 ext. 0026 (voice) or (800) 993-2822 (TTY). Mailing address: 1331 F Street, N.W., Suite 1000; Washington, D.C. 20004-1111.